Connie H. Miller - Concepedia

Author

Connie H. Miller

Centers for Disease Control and Prevention ORCID

Also Known As

C H Miller, C Miller, C. H. MILLER, C. H. Miller, C. Miller, C.H. MILLER, C.H. Miller, CONNIE H. MILLER, CONNIE MILLER, Connie H Miller

147

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities Emory University Johnson University Cornell University

About

Connie H. Miller is an author at Centers for Disease Control and Prevention specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	1.4K
2	Public Health	12	12	403
3	Health Sciences	5	5	364
4	Allergy	4	4	182
5	Biochemistry	1	1	24

Connie H. Miller

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
The Relationship of the Factor V Leiden Mutation and Pregnancy Outcomes for Mother and Fetus Donna Dizon‐Townson, Connie H. Miller, Baha M. Sibai, Obstetrics and Gynecology	2005	257
Platelet functional defects in women with unexplained menorrhagia Claire S. Philipp, Anne Dilley, Connie H. Miller, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisPlatelet Functional DefectsBlood PlateletHematology	2003	161
Age and the Prevalence of Bleeding Disorders in Women With Menorrhagia Claire S. Philipp, Ambarina S. Faiz, Nicole F. Dowling, Obstetrics and Gynecology	2005	148
Impact of inhibitors on hemophilia a mortality in the <scp>U</scp>nited <scp>S</scp>tates Christopher Walsh, J. Michael Soucie, Connie H. Miller American Journal of Hematology	2015	148
Measurement of von Willebrand factor activity: relative effects of ABO blood type and race Connie H. Miller, EC Haff, S. Jean Platt, Journal of Thrombosis and Haemostasis ThrombosisAllergyAbo Blood TypeMedicinePhysiology	2003	138
Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid Peter A. Kouides, Vanessa R. Byams, Claire S. Philipp, British Journal of Haematology GynecologyPharmacotherapyMenstrual CycleThrombosisOral Tranexamic Acid	2009	135
<i>F8</i> and <i>F9</i> mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity Connie H. Miller, J M Benson, Dorothy Ellingsen, Haemophilia	2011	130
Validation of Nijmegen–Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance Connie H. Miller, S. Jean Platt, A. Rice, Journal of Thrombosis and Haemostasis Therapeutic Drug MonitoringPreclinical Drug EvaluationMedicineInhibitor SurveillancePharmacology	2012	107
Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African‐American women Connie H. Miller, Anne Dilley, Lisa C. Richardson, American Journal of Hematology	2001	89
Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres J. Michael Soucie, Connie H. Miller, Brandi Dupervil, Haemophilia	2020	89

Page 1